-
Product Insights
Colon Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Colon Cancer Pipeline Products Market Report Overview Colon cancer is cancer that starts in the large intestine (colon). There is no single cause of colon cancer. Nearly all colon cancers begin as noncancerous (benign) polyps, which slowly develop into cancer. Many cases of colon cancer have no symptoms. The following symptoms may indicate colon cancer abdominal pain and tenderness in the lower abdomen, blood in the stool, diarrhea, constipation, or other change in bowel habits, narrow stools, and weight loss...
-
Product Insights
Net Present Value Model: RZ-358
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model RZ-358 Drug Details RZ-358 (XOMA-358) is...
-
Product Insights
Net Present Value Model: Iscalimab
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Iscalimab Drug Details Iscalimab is under...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – XOMA-213
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry XOMA-213 Drug Details XOMA-213 (LFA-102) is under development for the treatment of various hyperprolactinemias....
-
Product Insights
Behcet Disease Disease – Global Clinical Trials Review, H2, 2020
GlobalData's clinical trial report, “Behcet Disease Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Behcet Disease Clinical trials scenario. This report provides top line data relating to the clinical trials on Behcet Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also...
-
Product Insights
Posterior Uveitis Disease – Global Clinical Trials Review, H2, 2020
GlobalData's clinical trial report, “Posterior Uveitis Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Posterior Uveitis Clinical trials scenario. This report provides top line data relating to the clinical trials on Posterior Uveitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also...